Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Canadian launch for antiobesity drug

Jan. 14, 1997

Genetics Institute reports new bone morphogenic protein

Jan. 14, 1997

Thomae reports agents for hypercholesterolemia

Jan. 14, 1997

Positive phase III results reported for SCF

Jan. 13, 1997

Millennium/Roche obesity collaboration results in another significant discovery

Jan. 13, 1997

New approach to obesity gene research at Lilly

Jan. 13, 1997

Pramlintide can be mixed with insulin

Jan. 10, 1997

Sugen reports efficacy of novel antidiabetic drugs at H&Q conference

Jan. 10, 1997

Harvard Scientific to present impotence abstract

Jan. 10, 1997

New insights into melanocortin role in obesity

Jan. 9, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 25, 2026.
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026